<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02859285</url>
  </required_header>
  <id_info>
    <org_study_id>IRB # 15-18</org_study_id>
    <nct_id>NCT02859285</nct_id>
  </id_info>
  <brief_title>A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women</brief_title>
  <official_title>Sexual Function in Postmenopausal Women: A Double Blinded, Randomized Pilot Study Evaluating the Effects of Topical Clitoral Estradiol Cream</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ProHealth Care, Inc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ProHealth Care, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to learn about sexual function in postmenopausal women
      and to determine whether the use of topical clitoral application of estradiol improves
      women's libido, arousal, and orgasmic ability.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>19 point validated Female Function Index.</measure>
    <time_frame>Baseline then change over time at week 4,8,12</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>36 point RAND health survey.</measure>
    <time_frame>Baseline then change over time at week 4,8,12.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>10 point Likert scale</measure>
    <time_frame>Baseline then change over time at week 4,8,12.</time_frame>
    <description>Visual Analog Scale to measure improvement in libido, arousal and orgasm.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hypoactive Sexual Desire Disorder</condition>
  <arm_group>
    <arm_group_label>Estradiol vulvar cream</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The estradiol cream 0.5 grams will be placed on the clitoris/vestibule every night for 2 weeks, then 3 times a week thereafter on Monday, Wednesday, and Friday, for a total of 12 weeks.
In addition estradiol 10mcg tablet will be placed in the vaginal every night for 2 weeks, then 2x a week on Tuesday and Thursday, for a total of 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo cream</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo cream 0.5 grams will be placed on the clitoris/vestibule every night for 2 weeks, then 3 times a week thereafter on Monday, Wednesday, and Friday, for a total of 12 weeks.
In addition estradiol 10mcg tablet will be placed in the vaginal every night for 2 weeks, then 2x a week on Tuesday and Thursday, for a total of 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo vulvar cream</intervention_name>
    <arm_group_label>Placebo cream</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Estradiol vulvar cream</intervention_name>
    <arm_group_label>Estradiol vulvar cream</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sexually active postmenopausal women of any age with complaint of vulvar and/or
             vaginal atrophy who also complain of bothersome decreased libido, and/or arousal,
             and/or orgasmic dysfunction

        Exclusion Criteria:

          -  Not sexually active with a partner or an arousal device

          -  Uncontrolled diabetes as defined by having a consistent blood sugar level of over 100
             mg/dL

          -  Uncontrolled hypertension as defined by an average systolic blood pressure ≥140 mmHg
             or an average diastolic blood pressure ≥90 mmHg, among those with hypertension

          -  Allergic to estradiol

          -  Contraindications to estradiol such as undiagnosed abnormal genital bleeding;
             known/suspected or history of breast cancer; known/suspected estrogen-dependent
             neoplasm; active deep vein thrombosis, pulmonary embolism; active or recent stroke or
             myocardial infarction; liver dysfunction or disease

          -  Spanish speaking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Deb Ketterhagen, MSN</last_name>
    <phone>2629284061</phone>
    <email>debra.ketterhagen@phci.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Waukesa Memorial Hospital</name>
      <address>
        <city>Waukesha</city>
        <state>Wisconsin</state>
        <zip>53188</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deb Ketterhagen, MSN</last_name>
    </contact>
    <investigator>
      <last_name>Jodi Wilde, MSN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarit Aschkenazi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2016</study_first_posted>
  <last_update_submitted>September 20, 2017</last_update_submitted>
  <last_update_submitted_qc>September 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ProHealth Care, Inc</investigator_affiliation>
    <investigator_full_name>Deb Ketterhagen</investigator_full_name>
    <investigator_title>Advance Practice Nurse- Women's Center</investigator_title>
  </responsible_party>
  <keyword>Arousal</keyword>
  <keyword>Orgasm</keyword>
  <keyword>Clitoral</keyword>
  <keyword>Estradiol</keyword>
  <keyword>Post Menopausal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estradiol</mesh_term>
    <mesh_term>Polyestradiol phosphate</mesh_term>
    <mesh_term>Estradiol 3-benzoate</mesh_term>
    <mesh_term>Estradiol 17 beta-cypionate</mesh_term>
    <mesh_term>Estradiol valerate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

